New route into cells could make gene therapies safer

A new study by the Centenary Institute and the Sydney Local Health District has found that a specialised blood test can detect alcohol use in people with liver disease far more accurately than commonly used biomarker tests or patient self-reports. The breakthrough could help clinicians make better treatment decisions and guide eligibility for liver transplants.

The Centenary Institute recently hosted Science for Sight: Shaping the Future of Eye Health, a community event designed to raise awareness of eye disease and its impact on people’s lives. The program focused on keratoconus, limbal stem cell deficiency (LSCD) and dry eye syndrome, bringing together the latest in medical research with personal stories of lived experience.

A new study led by the Centenary Institute and the University of Sydney shows that a nasal vaccine could offer powerful protection against COVID-19. It works by stopping infection in the nose before the virus spreads through the body.

A breathtaking collection of images capturing the wonder and complexity of medical science has been unveiled through the Centenary Institute’s 2025 When Art Meets Science image prize competition.

A recent discovery from the Centenary Institute has been recognised as the 200th scientific breakthrough funded by cancer charity Tour de Cure since it began supporting research in 2007.

Professor Geoff McCaughan, senior researcher at the Centenary Institute’s Centre for Cancer Innovations, has shared his expert insights on ABC radio, discussing the growing global burden of liver cancer.

The Centenary Institute and Cure The Future Foundation have announced a new philanthropic partnership to accelerate research into life-changing treatments for rare genetic diseases and cancers.

A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney has shown strong potential to protect against both current and emerging coronavirus variants. By targeting features shared by a range of coronaviruses, the vaccine is designed to offer broader and longer-lasting protection as the virus continues to evolve.

Scientists from the Centenary Institute and the University of Sydney have made a landmark discovery that could lead to safer and more effective gene therapies for a range of serious genetic disorders including Duchenne muscular dystrophy, Pompe disease and haemophilia.

Two researchers from the Centenary Institute have secured competitive Pipeline Accelerator Grants from Therapeutic Innovation Australia (TIA), supporting the development of promising medical innovations.

A research team led by Professor Jennifer Gamble from the Centenary Institute’s Centre for Healthy Ageing has been awarded a prestigious Catalyst Partnership Grant from the Heart Foundation.

Professor Mark Gorrell from the Centenary Institute’s Centre for Cancer Innovations has been awarded a Springer Nature Editorial Contribution Award celebrating his outstanding editorial work for the highly respected journal Scientific Reports. The award recognises editorial board members who have made a notable contribution to the journal’s peer-review and publishing processes. Professor Gorrell has served ...